Biomol Ther.
2024 May;32(3):400-401. 10.4062/biomolther.2024.003.
Erratum to "Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy" [Biomol. Ther. 30 (2022) 418-426]
- Affiliations
-
- 1Department of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea
- 2Kangwon Institute of Inclusive Technology, Kangwon National University, Chuncheon 24341, Republic of Korea
- 3College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea
- KMID: 2555705
- DOI: http://doi.org/10.4062/biomolther.2024.003
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy
- Strategies for Manipulating T Cells in Cancer Immunotherapy
- Tumour Regression via Integrative Regulation of Neurological, Inflammatory, and Hypoxic Tumour Microenvironment
- Erratum to "Conformational Dynamics of Sclerostin-LRP6 Complex Analyzed by HDX-MS" [Biomol. Ther. 29 (2021) 527-535]
- Erratum to "Synthetic Homoisoflavane Derivatives of Cremastranone Suppress Growth of Colorectal Cancer Cells through Cell Cycle Arrest and Induction of Apoptosis" [Biomol. Ther. 30 (2022) 576-584]
